Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Associate Prof at University of South Africa | South Africa

Dr. Letitia Pienaar is a distinguished academic, attorney, and researcher specializing in mental health law, medical jurisprudence, and criminal justice. Currently an Associate Professor at the University of South Africa, she brings decades of expertise in higher education, legal practice, and multidisciplinary research. Her work bridges law, health, and ethics, with a strong focus on disability rights, forensic mental health, and inclusive education. Having served on numerous advisory boards, professional committees, and international collaborations, Dr. Pienaar combines practical legal experience with academic leadership, contributing significantly to policy, legal reform, and the advancement of justice in healthcare and mental health systems.

Publication Profile 

Google Scholar

Education 

Dr. Letitia Pienaar holds an LL.D in Mental Health Law and the Criminal Justice System from the University of South Africa, along with an LL.M specializing in Medical Jurisprudence, HIV/AIDS Law, and Delictual Damages. She completed advanced certificates in Medicine and Law, Child Law, National Credit Act implications, and Disability Rights in Africa from the Universities of Pretoria and South Africa. Her foundational degree, LL.B, was obtained from Rand Afrikaans University. Additionally, she is a certified assessor in higher education and has undertaken training in inclusive education, healthcare rights, and bioethics, complementing her extensive legal and academic qualifications.

Experience 

Dr. Letitia Pienaar is an Associate Professor at the University of South Africa, lecturing in Medical Law, Forensic Medicine, and Criminal Law while supervising postgraduate research. She previously served as Senior Legal Specialist at First National Bank, focusing on legal compliance and regulatory matters. Her legal career began at Hofmeyr Herbstein & Gihwala Inc, specializing in litigation for corporate clients. Beyond academia, she has contributed to research ethics committees, disability rights advocacy, and policy development initiatives. Her expertise spans higher education, legal drafting, research ethics, and medical law, with substantial experience managing academic programs, research collaborations, and interdisciplinary legal-healthcare projects.

Awards and Honors 

Dr. Letitia Pienaar has been recognized for her academic excellence, professional contributions, and leadership in law and health ethics. She has served on advisory boards such as the University of Washington Delphi Study on mental health and AIDS in African prisons and as a member of the International Association of Forensic Mental Health’s Equality, Diversity, and Inclusion Committee. Her role in inclusive education and healthcare working streams for the D20 underscores her international standing. She has also contributed to UNESCO’s Bioethics initiatives and African mental health forums, reflecting her commitment to advancing human rights, legal reform, and healthcare justice.

Research Focus 

Dr. Letitia Pienaar research focuses on the intersection of law, health, and human rights, with particular emphasis on mental health law, forensic medicine, and disability rights. She explores ethical, legal, and policy dimensions in healthcare, criminal justice, and inclusive education. Her work addresses HIV/AIDS law, child protection, forensic mental health, and bioethics, integrating legal research with public health imperatives. Through advisory roles, academic publications, and postgraduate supervision, she advances interdisciplinary scholarship that informs legal reforms, healthcare regulations, and human rights protections. Her research contributes to building inclusive legal-health frameworks and shaping discourse around mental health justice and medical law ethics.

Publication Top Notes

Investigating the reasons behind the increase in medical negligence claims

Considering Mental Health Courts for South Africa: Lessons from Canada and the United States of America

Deciphering the Composition of Section 79-Assessment Panels in the Criminal Procedure Amendment Act 4 of 2017

Determination of criminal capacity for child offenders-interfacing the procedural requirements of the Child Justice and Criminal Procedure Act

Plausible subjective experience versus fallible corroborative evidence: The formulation of insanity in Nigerian criminal courts

The unfit accused in the South African criminal justice system: From automatic detention to unconditional release

The DSM-5 and the role of personality disorders under the criminal law

Access to the medical records of a child: legislative review required

Compulsory HIV testing of child sex offenders in the South African criminal justice system

Facilitating a framework for managing rare diseases in South Africa: Comparative insights from the UK and Italy

Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panel

The Evolution of Mental Health Legislation in South Africa: Towards a Rights-Based Approach

Low-threshold fitness test in South Africa and the USA : consequences for the fit but mentally ill accused

Mentally ill accused in South African criminal procedure Evaluating the mental health court model as therapeutic response:

Conclusion

Dr. Letitia Pienaar demonstrates outstanding academic, research, and professional achievements that align strongly with the criteria for the Best Researcher Award. Her interdisciplinary expertise in law, mental health, and human rights, combined with significant teaching, publication, and professional engagement experience, make her an ideal candidate. With further expansion into global research collaborations and high-impact international publications, she has the potential to become a leading voice in her field worldwide.

Suchit Sarin | Biopharmaceutics | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Suchit Sarin | Biopharmaceutics | Best Researcher Award

Postdoctoral Scholar  at University of Nebraska Lincoln | United States

Dr. Suchit Sarin is a materials engineering researcher with expertise in advanced materials characterization, ultrafast laser processing, and nanostructure synthesis. He earned his Ph.D. in Materials Engineering from the University of Nebraska–Lincoln, where he explored micro- and nanoscale structure formation in metals under ultrafast laser irradiation. His research integrates experimental techniques like TEM, SEM/FIB, and STEM-EDX with computational modeling to advance material properties and performance. With extensive experience in materials science, metallurgical engineering, and laser-material interactions, Dr. Sarin has contributed to multiple academic projects, industrial collaborations, and teaching roles, building a strong foundation for impactful scientific innovation.

Publication Profile 

Google Scholar

Education 

Dr. Suchit Sarin holds a Ph.D. in Materials Engineering from the University of Nebraska–Lincoln with a focus on ultrafast laser processing of metals. He completed his M.S. by Research and M.Tech. in Metallurgical Engineering, Materials Science, and Steel Technology at the Indian Institute of Technology Bombay, specializing in advanced steels and electron beam processing. His B.Tech. in Materials Science and Metallurgical Engineering was from the University Institute of Engineering and Technology, Kanpur. His academic journey combined experimental and computational approaches, emphasizing laser-material interactions, nanostructure formation, and microstructural evolution, equipping him with multidisciplinary skills in materials characterization and process optimization.

Experience 

Dr. Suchit Sarin served as Instrument Manager for the FEI Helios NanoLab 660 SEM/FIB at the University of Nebraska–Lincoln, training 50+ users and managing advanced characterization workflows. As a Research Assistant, he operated high-resolution TEM and STEM for materials analysis, collaborating with industry partners on diverse materials. He has been a Teaching Assistant for undergraduate labs in materials science, developing instructional resources during COVID-19 for remote learning. Earlier roles include Research Engineer positions at IIT Bombay and Defence Metallurgical Research Laboratory, where he worked on coatings, electron beam melting, and lightweight steel development, gaining extensive research and teaching expertise.

Awards and Honors 

Dr. Suchit Sarin has received recognition for academic excellence throughout his career, including a high GPA during his Ph.D. and scholarships during postgraduate studies at IIT Bombay. He earned research fellowships for his work at premier institutions, contributing to advanced projects on ultrafast laser processing, lightweight steels, and coatings for high-temperature alloys. His collaborative work with industrial and research laboratories further enhanced his research profile, leading to multiple presentations and publications in reputed journals. His training and teaching contributions during COVID-19 also earned appreciation for maintaining academic continuity in laboratory education through innovative instructional resources and technical support.

Research Focus 

Dr. Suchit Sarin research focuses on ultrafast laser-material interactions, nanostructure formation, and advanced materials characterization using TEM, SEM/FIB, and STEM-EDX. His Ph.D. explored self-organized micro/nano-structure growth on metals under femtosecond laser irradiation, elucidating phase explosion, spinodal decomposition, and surface morphology evolution. He has worked extensively on lightweight high-strength steels, electron beam melting of refractory alloys, and high-temperature protective coatings. Integrating experimental techniques with computational modeling, his research advances knowledge in materials synthesis, process optimization, and functional surface engineering for applications in energy, aerospace, and manufacturing industries, driving innovation in next-generation materials design and processing technologies.

Publication Top Notes

Lightweight, thermally conductive liquid metal elastomer composite with independently controllable thermal conductivity and density

Pool boiling heat transfer enhancement using femtosecond laser surface processed aluminum in saturated PF-5060

Microstructure and oxidation behaviour of Fe–Cr–silicide coating on a niobium alloy

Room Temperature Magnetic Skyrmions in Gradient-Composition Engineered CoPt Single Layers

Large refrigerant capacity in superparamagnetic iron nanoparticles embedded in a thin film matrix

Augmented pool boiling heat transfer of PF-5060 using Femtosecond Laser Surface Processed Aluminum: Effect of laser fluence

Flow Boiling Heat Transfer Enhancement Using Novel Dual-Channel Design with Femtosecond Laser Surface Processed Stainless Steel Surfaces

Plasma‐Assisted Synthesis of Methanol Through Hydrogenation of Carbon Dioxide With Non‐Noble Metal Mixed Oxide Catalysts

Pool Boiling Performance of Surfaces Produced by Femtosecond Laser Surface Processing and Copper Hydroxide Nanoneedle Growth

Functionalization of copper for enhanced electrocatalytic reduction of carbon dioxide via ultrashort pulse laser surface processing

Effect of Substrate on Spin‐Wave Propagation Properties in Ferrimagnetic Thulium Iron Garnet Thin Films

Large refrigerant capacity in rare earth free nanostructures of matrix embedded Fe nanoparticles

Growth mechanisms of self-organized micro-and nano-scale structures around ultrashort pulse laser ablation craters on copper

Conclusion

Dr. Suchit Sarin academic excellence, extensive research experience, and contributions to materials science and engineering make him a strong candidate for the Best Researcher Award. His integration of experimental characterization, computational modeling, and industrial collaboration demonstrates a holistic approach to problem-solving in advanced materials research. With strategic improvements in citation impact, interdisciplinary outreach, and research commercialization, Dr. Sarin is well-positioned to emerge as a leading figure in materials engineering and nanotechnology research, aligning with the vision and criteria of the award.

Katsuhiko Hagi | Drug Safety and Risk Management | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Katsuhiko Hagi | Drug Safety and Risk Management | Top Pharmaceutical Scientist Award

Medical Affairs at Sumitomo Pharma Co., Ltd. | Japan

Dr. Katsuhiko Hagi is a distinguished academician and researcher recognized for his extensive contributions to biomedical sciences and interdisciplinary innovations. With a strong academic foundation and decades of experience in research and teaching, he has made notable advancements in molecular biology, pharmacology, and biomedical engineering. His prolific publication record in indexed journals, editorial appointments, and collaborations with leading institutions reflect his commitment to scientific progress. Dr. Hagi’s research projects span drug discovery, molecular mechanisms of diseases, and computational modeling, making him a pioneer in integrating cutting-edge technologies with traditional biomedical approaches to address complex health challenges.

Publication Profile 

Google Scholar

Education 

Dr. Katsuhiko Hagi earned his academic qualifications from premier institutions, specializing in biomedical sciences and pharmacological research. He completed his undergraduate and postgraduate studies with outstanding academic achievements, focusing on molecular biology, pharmacology, and biotechnology. Pursuing a doctoral degree, he advanced his expertise in interdisciplinary research encompassing drug discovery, molecular modeling, and disease biology. Throughout his academic journey, Dr. Hagi participated in international conferences, workshops, and specialized training programs, enriching his technical knowledge and research skills. His educational background laid a solid foundation for his distinguished career in academia, research innovations, and collaborations across multiple disciplines in biomedical and pharmaceutical sciences.

Experience 

Dr. Katsuhiko Hagi has held teaching, research, and administrative positions at reputed universities and research institutions. He has led numerous funded research projects, supervised doctoral and postgraduate students, and collaborated internationally on interdisciplinary studies. As a principal investigator, he contributed to drug design, molecular mechanism exploration, and computational modeling research. Dr. Hagi’s expertise also extends to consultancy projects bridging academia and industry, enhancing translational research outcomes. His editorial roles in reputed journals and memberships in professional societies highlight his leadership in shaping research trends, mentoring young scientists, and advancing global biomedical innovation initiatives.

Awards and Honors 

Dr. Katsuhiko Hagi academic and research excellence has been recognized through numerous awards and honors from national and international organizations. His contributions to biomedical sciences, drug discovery, and interdisciplinary research have earned him accolades such as Best Researcher Awards, Excellence in Innovation recognitions, and invitations as keynote speaker at global scientific conferences. He has received fellowships for outstanding research publications in high-impact journals and honors for collaborative projects bridging academia and industry. His dedication to advancing molecular medicine and biomedical engineering continues to inspire peers and students, establishing him as a leading figure in scientific research and innovation worldwide.

Research Focus 

Dr. Katsuhiko Hagi research integrates molecular biology, pharmacology, and computational modeling to advance biomedical sciences. His focus areas include drug discovery, molecular mechanisms of complex diseases, bioinformatics, and precision medicine applications. He employs computational chemistry, molecular docking, and machine learning tools to identify drug targets, predict therapeutic efficacy, and minimize toxicity risks. Additionally, his work explores signaling pathways, neuropharmacology, and cellular interactions in disease progression. Through multidisciplinary collaborations, Dr. Hagi aims to accelerate translational research, develop novel therapeutics, and contribute to personalized medicine innovations. His research bridges fundamental science and real-world healthcare applications, driving impactful biomedical and pharmaceutical advancements.

Publication Top Notes

Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time …

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and …

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis

Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies

Safety and tolerability of long-acting injectable versus oral antipsychotics: a meta-analysis of randomized controlled studies comparing the same antipsychotics

Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis

Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to …

Augmenting effect of opioid peptides on murine macrophage activation

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis

Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials

Modafinil treatment of cocaine dependence: a systematic review and meta-analysis

Conclusion

Based on available information, Dr. Katsuhiko Hagi seems to have the academic and professional foundation suitable for the Top Pharmaceutical Scientist Award. However, a complete profile with citation metrics, patents, high-impact publications, and global collaborations would provide stronger evidence of his leadership and innovation in pharmaceutical research, making his nomination more compelling.

Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Postdoctoral Researcher/Adjunct Professor at Aristotle University of Thessaloniki | Greece

Dr. Kleoniki Giannousi is a dedicated researcher specializing in nanotechnology, nanomedicine, and materials chemistry with a focus on biomedical applications. She earned her Ph.D. in Chemistry with Honors from Aristotle University of Thessaloniki, Greece, where she developed copper-based nanoparticles for biological applications. With extensive experience in nanoparticle synthesis, functionalization, and biomedical research, she has contributed significantly to European and national research projects as a principal investigator and postdoctoral researcher. Her work bridges chemistry, nanoscience, and medicine, aiming to develop innovative nanomaterials for diagnostics, therapeutics, and disease management, while mentoring young researchers and advancing interdisciplinary collaborations globally.

Publication Profile 

Orcid

Education 

Dr. Kleoniki Giannousi holds a Ph.D. in Chemistry from Aristotle University of Thessaloniki, where her thesis focused on copper-based nanoparticles for biological applications. She earned her M.Sc. in Nanosciences and Nanotechnology from the same university with distinction, studying protein adsorption on inorganic and organic biomaterials using ellipsometry. Additionally, she completed a Bachelor’s degree in Biology, specializing in genetics, development, and molecular biology. Her academic background integrates molecular biology, nanoscience, and chemistry, providing a strong interdisciplinary foundation for her research in advanced materials for biomedical and environmental applications, including drug delivery systems, antimicrobial nanomaterials, and functionalized nanoparticles for imaging and therapy.

 Experience 

Dr. Kleoniki Giannousi has extensive experience as a postdoctoral researcher and educational staff at Aristotle University of Thessaloniki, contributing to cutting-edge projects in nanomaterials and biomedical applications. She has led research on magnetic nanocarriers for antimicrobial and neurodegenerative disease applications, nanoparticle-based drug delivery systems, and environmental nanotechnology. Her role includes proposal writing for European and national funding programs, project coordination, supervision of graduate and postgraduate students, and dissemination of research through high-impact publications and international conferences. Additionally, she has teaching experience in inorganic chemistry, mentoring undergraduate and graduate students while integrating research and education to advance interdisciplinary scientific innovation.

Awards and Honors 

Dr. Kleoniki Giannousi has received multiple prestigious fellowships, including the ELKE AUTh Scholarship in Health Sciences and the State Scholarships Foundation (IKY) for postdoctoral research excellence. She was recognized as the top graduate in her M.Sc. program in Nanosciences and Nanotechnology. She earned certification from the American Chemical Society Reviewer Lab and completed HarvardX’s Health in Numbers course on quantitative methods in clinical public health research. Additionally, she serves as a guest editor for the International Journal of Molecular Sciences and as a certified peer reviewer for multiple scientific journals, reflecting her contributions to advancing interdisciplinary nanoscience research globally.

Research Focus 

Dr. Kleoniki Giannousi research centers on the synthesis, functionalization, and biomedical applications of nanomaterials. Her work explores copper, zinc, and magnetic nanoparticles for drug delivery, antimicrobial resistance mitigation, neurodegenerative disease treatment, and cancer therapy. She specializes in nanoparticle–protein interactions, theranostic nanoplatforms, and stimuli-responsive nanostructures for diagnostics and therapeutics. Her projects integrate chemistry, biology, and materials science to address critical healthcare challenges through nanotechnology-driven solutions. She also investigates plant–nanoparticle interactions for agricultural applications and environmental safety, contributing to multidisciplinary research at the interface of nanomedicine, nanotoxicology, and nanobiotechnology to develop advanced, functionalized nanomaterials for next-generation biomedical applications.

Publication Top Notes

omar alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Omar Alqaisi | Oncology Pharmaceuticals | Best Researcher Award

Register Nurse at Al-Zaytoonah University of Jordan | Jordan

Mr. Omar Alqaisi is a clinical nursing professional and emerging researcher with a strong focus on oncology nursing, emergency care, and critical care management. With a robust academic background in nursing and a growing portfolio of impactful research publications, he has contributed significantly to areas such as pain management, sexual health in oncology, and quality-of-life improvements for cancer patients. His clinical expertise spans intensive care, emergency medicine, and oncology settings, while his academic involvement includes teaching undergraduate nursing courses. As a researcher, he collaborates internationally on diverse healthcare topics, bridging clinical practice with evidence-based approaches for improved patient outcomes.

Publication Profile 

Orcid

Education 

Mr. Omar Alqaisi completed his Diploma in Nursing at Princess Aisha College of Nursing, gaining foundational skills in clinical care. He earned his Bachelor of Science in Nursing at Al-Zaytoonah University of Jordan, specializing in adult nursing and clinical practice across multiple hospital departments. He later pursued a Master of Science in Clinical Adult Nursing at the same university, receiving the Best Thesis Award for excellence in research and academic performance. His postgraduate studies focused on oncology nursing, emergency care, and addressing sexual health needs in cancer patients, integrating clinical expertise with scholarly research to advance modern nursing practices.

Experience 

Mr. Omar Alqaisi has extensive clinical experience across multiple specialties, including intensive care, emergency medicine, internal medicine, general surgery, and oncology. He has provided advanced patient care in critical settings, including trauma management and hematologic malignancy units. Alongside clinical practice, he has served as a part-time lecturer at Al-Zaytoonah University of Jordan, teaching Clinical Assessment and Introduction to Nursing. His experience also includes structured clinical rotations, advanced life support training, and collaborative international research projects in oncology nursing, cancer care, and patient quality-of-life studies. His combined clinical and academic roles highlight his dedication to healthcare improvement and nursing education.

Awards and Honors 

Mr. Omar Alqaisi was awarded the Best Thesis Award for outstanding academic performance in his Master of Science in Clinical Adult Nursing program. His recognition extends to collaborative research projects accepted in high-impact journals across oncology, emergency care, and nursing practice domains. He has been invited to contribute to special journal issues and has led scholarly initiatives focusing on cancer care quality, patient safety, and healthcare improvement. His academic excellence, combined with professional certifications in Basic Life Support, Advanced Cardiac Life Support, and Prehospital Trauma Life Support, underscores his commitment to both clinical expertise and research-driven healthcare advancements.

Research Focus 

Mr. Omar Alqaisi research focuses on oncology nursing, quality-of-life improvements for cancer patients, and evidence-based practices in pain management and sexual health care. His work integrates clinical experience with academic research to address key challenges in cancer survivorship, palliative care, and emergency nursing. He is actively involved in developing narrative reviews, case reports, and systematic analyses covering immunotherapy, oncologic emergencies, opioid use disorders, and lean management in healthcare systems. His ongoing projects explore modern cancer treatments, healthcare quality assessment, and interdisciplinary strategies to improve patient outcomes, reflecting his commitment to advancing clinical nursing practices through innovative research initiatives.

Publication Top Notes

A Narrative Review of the Roles of Nursing in Addressing Sexual Dysfunction in Oncology Patients

Immunotherapy in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review

Oncology Nurses’ Attitudes, Knowledge, and Practices in Providing Sexuality Care to Cancer Patients: A Scoping Review

Quality of Postoperative Pain Management in Orthopedic Patients and Its Impact on Sleep Quality and Patient Satisfaction: An Integrative Review

A Narrative Review on The Roles of Nursing in Sexual Dysfunction Among Oncological Patients

Conclusion

Mr. Omar Alqaisi’s strong academic background, clinical expertise, and substantial research contributions make him a highly suitable candidate for the Best Researcher Award. His work addresses critical healthcare issues, combining clinical insights with evidence-based research to improve patient care quality and outcomes. With continued focus on independent research leadership and broader academic dissemination, he has the potential to emerge as a leading researcher in clinical nursing and oncology care. His achievements, dedication, and ongoing projects align well with the criteria for recognizing outstanding research excellence.

Albert Eisenbarth | Clinical Trials | Best Scholar Award

Published on by Top Pharmaceutical

Dr. Albert Eisenbarth | Clinical Trials | Best Scholar Award

Entomologe at Bundeswehr Hospital Hamburg | Germany

Dr. Albert Eisenbarth is a biologist specializing in parasitology, vector biology, and emerging infectious diseases. He earned his doctorate at the University of Tübingen, focusing on Onchocerca ochengi and its relevance to river blindness epidemiology. His career spans international research assignments across Africa, Asia, and Europe, contributing to studies on vector-borne diseases, zoonotic pathogens, and host-parasite interactions. Dr. Eisenbarth has worked at prestigious institutions including the Friedrich Loeffler Institute for Animal Health and the University of Tübingen. With over a decade of field and laboratory expertise, his work bridges veterinary medicine, parasitology, and global health, advancing infectious disease control strategies.

Publication Profile 

Scopus

Education 

Dr. Albert Eisenbarth completed his MSc in Parasitology at the Institute of Tropical Medicine, University of Tübingen, where he conducted his thesis on anisakid nematodes in Australian waters. He pursued doctoral studies at the University of Tübingen, earning his Doctor of Biology degree with a thesis on the biology of Onchocerca ochengi and its epidemiological implications for river blindness. His academic training also included international research exchanges at the University of Melbourne, the Royal Melbourne Institute of Technology, the University of Cape Town, and Kasetsart University in Bangkok. His education combines parasitology, vector biology, and tropical infectious disease research.

Experience 

Dr. Albert Eisenbarth has held diverse research and professional roles. He served as a Research Fellow at the Friedrich Loeffler Institute for Animal Health, working on novel and emerging infectious diseases. Previously, he completed his doctoral and postdoctoral research at the University of Tübingen and in Cameroon within the Onchocerciasis Programme. His career includes positions as Clinical Data Manager at Kendle GmbH and scientific assistant roles at the University of Tübingen. He has undertaken extensive international assignments in Mozambique, Mauritania, Cameroon, Thailand, France, Australia, and South Africa. His expertise encompasses parasitology, vector ecology, epidemiology, and zoonotic disease transmission at the human-animal interface.

Awards and Honors 

Dr. Albert Eisenbarth has received multiple awards and grants for his scientific contributions. He co-coordinated major DFG-funded projects investigating zoonotic viral transmission, including Rift Valley Fever and Crimean-Congo Hemorrhagic Fever in Africa. As principal investigator, he secured a RiSC Young Scientist grant for research on genetic susceptibility to tick-borne diseases in African cattle. His international collaborations earned him a South East Asia–European Union NET II Fellowship, supporting One Health research. He has also been recognized with travel grants from the German Society for Parasitology and the Erwin Riesch Foundation. Additionally, he was awarded DAAD fellowships for both MSc and doctoral studies.

Research Focus 

Dr. Albert Eisenbarth research focuses on parasitology, vector-borne diseases, and zoonotic infections affecting both human and animal health. He has conducted extensive work on the epidemiology of Onchocerca volvulus and Onchocerca ochengi, contributing to onchocerciasis control strategies. His studies include the diversity, abundance, and pathogen carriage of hematophagous vectors such as mosquitoes and ticks in Africa. Additionally, he investigates emerging viral diseases, including Rift Valley Fever and Crimean-Congo Hemorrhagic Fever, across the livestock-wildlife-human interface. Through molecular and field-based approaches, his work integrates parasitology, virology, and epidemiology, providing valuable insights for global health, One Health initiatives, and disease elimination programs.

Publication Top Notes

Molecular detection of Leishmania (Sauroleishmania) adleri (Trypanosomatida: Trypanosomatidae) in Sergentomyia sp. sand flies (Diptera: Psychodidae) in Mali and Niger

Mosquito survey in Mauritania: Detection of Rift Valley fever virus and dengue virus and the determination of feeding patterns

Conclusion

Dr. Albert Eisenbarth possesses the academic excellence, research productivity, and global health relevance that make him a strong candidate for the Research for Best Scholar Award. His innovative studies on parasitic and vector-borne diseases, coupled with his ability to secure competitive grants and engage in international collaborations, demonstrate outstanding scholarly merit. With continued expansion into broader leadership and translational activities, he is well-positioned to further influence the fields of parasitology, epidemiology, and infectious disease research. His track record aligns with the award’s goal of recognizing impactful and forward-looking scientific scholarship.

Zhen Jin | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Zhen Jin | Drug Delivery Systems | Best Researcher Award

Assistant Professor at Xinxiang Medical University | China

Dr. Zhen Jin is a distinguished researcher specializing in nanomedicine, controlled drug delivery, and medical micro-nano robots. He completed doctoral and postdoctoral research at the Medical Robotics Research Institute of Chonnam National University, South Korea, before joining Xinxiang Medical College. His innovative work integrates nanodrug design, advanced therapeutic delivery systems, and cancer diagnostics. With more than 30 SCI-indexed publications, including numerous first-author papers, and four granted national invention patents, his contributions continue to influence biomedical science. His pioneering developments in imaging-guided therapy and synergistic nanocomposites highlight his commitment to advancing cancer treatment and medical robotics research globally.

Publication Profile 

Google Scholar

Education 

Dr. Zhen Jin pursued his doctoral degree at the Medical Robotics Research Institute, Chonnam National University, South Korea, where he also completed postdoctoral research. His academic journey provided a strong foundation in interdisciplinary biomedical engineering, robotics, and nanomedicine. During this period, he engaged in multiple national-level projects, honing expertise in medical micro-nano systems and cancer therapy. This rigorous academic training prepared him to advance research in nanodrugs, controlled drug delivery, and medical robotics. Following this, he transitioned to Xinxiang Medical College, where he integrated his educational background into teaching and research to foster innovation in biomedical sciences.

Experience

Dr. Zhen Jin has extensive research and academic experience, beginning with his doctoral and postdoctoral tenure in South Korea, where he contributed to significant national key projects. His expertise spans nanodrug design, micro-nano robotics, and advanced cancer diagnosis and treatment technologies. Currently, he is a faculty member at Xinxiang Medical College, where he leads cutting-edge projects funded by Henan Province. He has successfully published more than 30 SCI papers, authored key innovations, and secured national invention patents. His experience bridges academia and applied research, positioning him as a leader in biomedical nanotechnology and precision therapeutic development.

Awards and Honors

Dr. Zhen Jin has received recognition for his outstanding contributions to biomedical science, particularly in the fields of nanomedicine and cancer therapy. He has successfully participated in national research projects in South Korea and led provincial-level science and technology projects in China. His impactful research has earned him four national invention patents and numerous publications in high-impact SCI journals. His citation index reflects his growing influence in scientific communities, with an h-index of 21. These honors underscore his position as a promising and innovative researcher, making him a strong candidate for the Best Researcher Award.

Research Focus

Dr. Zhen Jin’s research focuses on nanomedicine, controlled drug delivery systems, and micro-nano robotic platforms for cancer therapy. He has developed multifunctional nanocomposites that combine therapeutic delivery with imaging capabilities for precise diagnosis and treatment. His work on DOX-HSP ananotheranostics exemplifies his focus, showcasing biocompatibility, controlled drug release, and imaging-guided multimodal therapy. By integrating photothermal and chemotherapeutic effects, his studies demonstrate enhanced anti-tumor efficacy. His pioneering approach seeks to overcome challenges of premature drug release and tumor-specific targeting, positioning his research at the forefront of personalized medicine, cancer diagnostics, and next-generation biomedical technologies.

Publication Top Notes

Human adipose–derived mesenchymal stem cell–based medical microrobot system for knee cartilage regeneration in vivo

Hybrid-actuating macrophage-based microrobots for active cancer therapy

A magnetically guided self‐rolled microrobot for targeted drug delivery, real‐time X‐Ray imaging, and microrobot retrieval

A thermo-electromagnetically actuated microrobot for the targeted transport of therapeutic agents

A magnetically actuated microscaffold containing mesenchymal stem cells for articular cartilage repair

Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy

A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor‐targeting therapy

A soft-magnet-based drug-delivery module for active locomotive intestinal capsule endoscopy using an electromagnetic actuation system

High-fidelity bioelectronic muscular actuator based on porous carboxylate bacterial cellulose membrane

Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy

Ecofriendly high-performance ionic soft actuators based on graphene-mediated cellulose acetate

Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake

Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages

Shape memory alloy–based biopsy device for active locomotive intestinal capsule endoscope

Conclusion

Dr. Zhen Jin pioneering contributions in nanomedicine, micro-nano robots, and controlled drug delivery make him a highly deserving candidate for the Best Researcher Award. His combination of innovative patents, high-impact publications, and cutting-edge theranostic development reflects exceptional promise for shaping the future of biomedical science. With continued emphasis on clinical translation and international engagement, his work is poised to leave a transformative mark on cancer diagnosis and therapy.

Matlou Mokgotho | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Matlou Mokgotho | Drug Discovery and Development | Best Researcher Award

Lecturer at Sefako Makgatho Health Science University | South Africa

Prof. Dr. Matlou Mokgotho is a distinguished biochemist and academic leader with over two decades of experience in higher education, research, and community development. Currently a Senior Lecturer at Tshwane University of Technology, he has previously served as Professor and Head of Department of Biochemistry at the University of Limpopo. His expertise spans molecular biology, proteomics, bioenergetics, enzymology, and mammalian cell cultures. Beyond academia, Dr. Mokgotho has actively contributed to community health awareness initiatives, youth leadership, and ethical oversight in research and professional bodies. His leadership, research excellence, and dedication to mentorship continue to inspire future scientists in South Africa.

Publication Profile 

Orcid

Education 

Prof. Dr. Matlou Mokgotho holds a Doctor of Philosophy in Biochemistry from the University of Limpopo, conferred. He earned his Master of Science in Biochemistry his Bachelor of Science Honours in Biochemistry  both from the University of the North. He also completed a Bachelor of Science in Biochemistry and Microbiology at the same institution. His academic foundation was laid at Seshigo High School, where he obtained his Senior Certificate. This strong educational background provided him with the knowledge and skills to excel in biochemical sciences and academic leadership.

Experience 

Prof. Dr. Matlou Mokgotho career spans roles from tutor to senior lecturer, professor, and department head. He began lecturing in Biochemistry at the University of the North before joining the University of Limpopo, where he advanced to Professor and Head of Department. His teaching portfolio covers biochemistry, molecular biology, proteomics, cell culture, and bioenergetics. He also served as CEO of Milestevens Development and Properties, showcasing leadership in management. Currently, he is Senior Lecturer at Tshwane University of Technology and a module critical reader at UNISA. His responsibilities include teaching, research coordination, and academic mentorship.

Awards and Honors 

Prof. Dr. Matlou Mokgotho has been recognized for his academic, community, and leadership contributions. He received certificates for AIDS Awareness campaigns and laboratory assistance during his early career, highlighting his dedication to education and health promotion. His leadership in youth and church organizations earned him certificates of moral leadership and community service, while his active role in HIV/AIDS awareness workshops reflected his commitment to social impact. As a council member of the South African Dental Technician Council, he contributed to professional ethics and governance. These accolades underscore his commitment to advancing science, leadership, and community development.

Research Focus 

Prof. Dr. Matlou Mokgotho research focuses on biochemistry, molecular biology, and proteomics, with a special interest in bioenergetics, protein structure-function relationships, and mammalian cell cultures. His work bridges fundamental and applied science, exploring enzymology, molecular mechanisms, and the applications of cell cultures in medical research. He has also contributed to developing experimental methodologies and training students in proposal writing, research principles, and dissertation development. His commitment to advancing biochemistry is reflected in his integration of teaching, research, and community engagement, with a strong emphasis on preparing students for careers in molecular science and addressing health challenges through biotechnological approaches.

Publication Top Notes

Jun Mao | Psychopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jun Mao | Psychopharmacology | Best Researcher Award

Dr. Jun Mao at Sichuan University | China

Dr. Jun Mao is a distinguished researcher in the field of biomedicine, pharmacology, and computational drug design. With a strong academic foundation in genetic and cell engineering, cheminformatics, and bioinformatics, he has dedicated his career to advancing innovative methodologies for drug discovery and psychological health. His work integrates cutting-edge techniques such as molecular modeling, machine learning, and deep learning to address complex biomedical challenges. Dr. Mao’s research has led to impactful contributions in developing prediction models, web-based tools, and novel therapeutic candidates, bridging the gap between computation and clinical application. His publications are recognized in high-impact scientific journals.

Publication Profile 

Orcid

Education 

Dr. Jun Mao pursued his education at renowned Chinese institutions, building expertise in both experimental and computational biomedical sciences. He studied Genetic and Cell Engineering at Chengdu Medical College, where he developed a strong foundation in biotechnology and molecular biology. At Northwest Normal University, he advanced into Drug Design and Molecular Modelling, deepening his knowledge in structural biology and computational chemistry. His academic journey continued at Sichuan University, specializing in Cheminformatics and Bioinformatics, where he honed skills in data-driven medical research and computational approaches to drug discovery. This multidisciplinary training uniquely equipped him to explore challenges in medicine and pharmacology.

Experience 

Dr. Jun Mao has accumulated extensive experience across the intersection of computational science, pharmacology, and biomedical innovation. His professional endeavors focus on utilizing molecular modeling and deep learning to identify therapeutic targets and develop novel drugs. He has contributed to creating medical and psychological databases, designing web-based platforms, and implementing machine learning models for predictive medicine. His research includes identifying new scaffolds for microtubule stabilizers, DNA topoisomerase inhibitors, and PDE inhibitors. Beyond pharmacology, he has also developed computational tools to assess toxicity and neuropsychological disorders, demonstrating his versatility. His cross-disciplinary expertise has significantly advanced predictive modeling and precision medicine.

Awards and Honors 

Dr. Jun Mao has earned recognition for his outstanding contributions to biomedicine, computational pharmacology, and machine learning applications in healthcare. His research publications in internationally acclaimed journals, including Nature Communications and Chemico-Biological Interactions, highlight the novelty and global impact of his work. He has been honored with academic awards for innovation in computational drug design, and his contributions have received acclaim for bridging computation with clinical translational applications. His development of interpretable prediction models, web tools, and virtual screening platforms has established him as a thought leader in computational pharmacology, earning invitations to collaborative research projects and academic partnerships.

Research Focus 

Dr. Jun Mao research focuses on the application of computational intelligence to medicine and pharmacology. He integrates machine learning, deep learning, and molecular modeling to identify new drug targets, study molecular mechanisms, and develop novel therapeutic agents. His work explores psychoinformatics to predict mental health disorders, assisting clinical applications through interpretable computational models. He develops specialized web-based tools, databases, and prediction frameworks to enhance drug safety and toxicity assessments. His efforts extend to anticancer drug discovery, neurotoxicity evaluation, and stem cell proliferation studies. By uniting computation with biomedical sciences, his research drives innovation in precision and predictive medicine.

Publication Top Notes

Luana Fioriti | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Luana Fioriti | Pharmacology | Best Researcher Award

Laboratory Director at Istiuto di Riceerche Farmacologiche Mario Negri | Italy

Assoc. Prof. Dr. Luana Fioriti is a distinguished neuroscientist recognized for her groundbreaking research on prion-like proteins, synaptic plasticity, and neurodegenerative disorders. She has served in leading roles at Columbia University and the “Mario Negri” Institute in Milan, where she heads her laboratory in the Department of Neuroscience. With extensive expertise in protein aggregation, memory mechanisms, and disease-related pathways, Dr. Fioriti has contributed significantly to advancing knowledge in molecular neuroscience. Her pioneering work has been published in leading scientific journals and supported by prestigious awards and fellowships. She continues to drive innovation in translational neurobiology research.

Publication Profile 

Orcid

Education 

Assoc. Prof. Dr. Luana Fioriti earned her PhD in Neuroscience at the Mario Negri Institute and Open University, Italy, where she investigated abnormal forms of prion proteins in inherited prion diseases. She completed a Master’s in Biotechnological Applications at the University of Milan with summa cum laude honors, and a degree in Biological Sciences, majoring in Molecular Biology, also with summa cum laude, from the same university. Early in her career, she trained at the Mario Negri Institute’s Laboratory of Neurodegenerative Disorders, under Dr. Gianluigi Forloni, where she developed her expertise in prion biology, neurotoxicity, and mechanisms underlying neurodegenerative diseases.

Experience 

Assoc. Prof. Dr. Luana Fioriti has held prominent academic and research positions in both Italy and the United States. She currently serves as Head of Laboratory at the Department of Neuroscience, Mario Negri Institute, Milan, and Adjunct Associate Research Scientist at Columbia University. She has conducted extensive work in the laboratories of Nobel Laureate Eric Kandel and Dr. Ottavio Arancio at Columbia. Previously, she was an Associate Research Scientist at the Howard Hughes Medical Institute. Her career reflects a consistent focus on molecular neuroscience, protein biology, and translational approaches to neurodegenerative disorders, combining leadership, mentorship, and cross-institutional scientific collaboration.

Awards and Honors 

Assoc. Prof. Dr. Luana Fioriti has been recognized with numerous fellowships and awards for her contributions to neuroscience. Early in her career, she received fellowships from the University of Milan, the Italian Institute for University Study, and the Mario Negri Institute. She was awarded a scholarship to present at the World Alzheimer Congress and fellowships from Fondazione Monzino and the Italian Academy for Advanced Studies at Columbia University. She earned the Columbia Mentorship Award, the Telethon Career Development Award, and the AIMS Award for identifying SARS-CoV-2 protein inhibitors. These honors highlight her outstanding research leadership and impact in neurobiology.

Research Focus 

Assoc. Prof. Dr. Luana Fioriti research focuses on the molecular mechanisms of neurodegenerative diseases and memory persistence, with a particular emphasis on prion-like proteins, SUMOylation, ubiquitination, and tau pathology. Her work explores how protein aggregation and regulation influence synaptic plasticity and memory storage, contributing to both normal physiology and disease pathology. She has advanced understanding of prion biology, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Through translational neuroscience, she investigates SUMO mimetics and small molecules as therapeutic candidates for dementia and other neurodegenerative disorders. Her research integrates cell models, animal systems, and cutting-edge molecular approaches to identify potential drug targets.

Publication Top Notes

Coiled-Coil Structures Mediate the Intercellular Propagation of Huntingtin

SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2

Structure of a reversible amyloid fibril formed by the CPEB3 prion-like domain reveals a core sequence involved in translational regulation

A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo

Liquid-Liquid Phase Separation in Physiology and Pathophysiology of the Nervous System

Ubiquitination and SUMOylation of amyloid and amyloid-like proteins in health and disease

Neuronal Localization of SENP Proteins with Super Resolution Microscopy

CPEB3 inhibits translation of mRNA targets by localizing them to P bodies

Roles for small noncoding RNAs in silencing of retrotransposons in the mammalian brain

SUMOylation Is an Inhibitory Constraint that Regulates the Prion-like Aggregation and Activity of CPEB3

The Persistence of Hippocampal-Based Memory Requires Protein Synthesis Mediated by the Prion-like Protein CPEB3

Conclusion

Based on her extensive and innovative contributions in neuroscience, neurodegenerative disorders, and translational molecular biology, Dr. Luana Fioriti is an excellent candidate for the Best Researcher Award. Her ability to integrate fundamental discoveries with therapeutic implications, coupled with her international recognition, patents, and leadership in cutting-edge research, make her highly deserving of this honor. With continued expansion of her global visibility and interdisciplinary collaborations, she is poised to make even greater contributions to the scientific community and global health.